Recent studies show that Eph receptors act mainly through the regulation of actin reorganization 1 . Here, we show a novel mode of action for EphB receptors. We identify synaptojanin 1 -a phosphatidylinositol 5´-phosphatase that is involved in clathrin-mediated endocytosis 2,3 -as a physiological substrate for EphB2. , and guanine nucleotide-exchange factors (GEFs) 7, 8 . Proteins that are phosphorylated by Eph receptors include non-receptor tyrosine kinases 9, 10 
ephrin-Eph signalling is a rapid change in cell shape, such as during growth cone collapse. However, the downstream effects of Eph receptor activation may not be restricted to actin cytoskeleton rearrangements.
To identify new pathways downstream of ligand-activated EphB receptors, we analysed proteins that are specifically tyrosine phosphorylated in response to ephrinB2 stimulation. For this purpose, we generated a neuroblastoma-like cell line that stably expresses EphB2 (B35-EphB2 cells). B35-EphB2 cells were treated for 15 min with an ephrinB2-Fc fusion protein multimerized with an anti-Fc antibody. Tyrosine-phosphorylated proteins were captured by anti-phosphotyrosine-agarose and separated by SDS-PAGE. Protein bands that were present in ephrinB2-treated cells but not in control Fc-treated cells were subjected to matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry analysis. One of the main bands identified in this experiment was the form of synaptojanin 1 that has a relative molecular mass of 145,000 (M r 145K) (see Supplementary  Information, Table S1 ), a phosphatidylinositol-phosphatase required for clathrin-mediated endocytosis 2, 3 . To confirm the biological significance of this observation, we investigated whether ephrinB-dependent phosphorylation of synaptojanin 1 occurs in cells in which both synaptojanin 1 and EphB2 are endogenously expressed. In cultured rat hippocampal neurons, ephrinB2 treatment caused phosphorylation of endogenous synaptojanin 1 as well as autophosphorylation of endogenous EphB2 (Fig. 1a) . Moreover, cotransfection assays using 293T cells showed that synaptojanin 1 is phosphorylated downstream of EphB2, but not kinase-inactive EphB2 or EphA4 (Fig. 1b) . Together, these results demonstrate that synaptojanin 1 is a physiological downstream target of EphB2 (and possibly other B-type Eph receptors), and suggest a role for ephrinB-EphB signalling in endocytosis.
Next we identified the EphB2-dependent tyrosine phosphorylation sites in synaptojanin 1. Synaptojanin 1 is a multidomain protein, which consists of a Sac1-homology domain, an inositol 5´-phosphatase domain, and a proline-rich domain (Fig. 1c) . In 293T cells that were transfected with EphB2, both a synaptojanin 1 deletion mutant lacking the Sac1-homology domain and another mutant lacking the 5´-phosphatase L E T T E R S domain were efficiently phosphorylated, whereas a deletion mutant that lacked the proline-rich domain was not phosphorylated (Fig. 1d ). This suggests that EphB2 causes phosphorylation in the proline-rich domain. The proline-rich domain contains three tyrosine residues: Tyr 1018 , Tyr 1059 and Tyr 1172 (Fig. 1c) . Point mutants at single tyrosine residues (designated as Y1018F, Y1059F, and Y1172F) were still phosphorylated downstream of EphB2 (left panel in Fig. 1e ). Mutation of two of the three tyrosine residues (Y1018F and Y1059F, Y1018F and Y1172F, or Y1059F and Y1172F) resulted in a significant reduction in phosphorylation, and mutation of all three tyrosine residues (Y1018F, Y1059F and Y1172F) completely eliminated phosphorylation (right panel in Fig. 1e ). These results indicate that EphB2-dependent phosphorylation of synaptojanin 1 occurs predominantly at these tyrosine residues in the proline-rich domain. Furthermore, the EphB2 kinase domain can directly phosphorylate the proline-rich domain of synaptojanin 1 in an in vitro phosphorylation assay using recombinant proteins (Fig. 1f) .
The proline-rich domain of synaptojanin 1 is known to be involved in protein interactions with SH3-domain-containing endocytic proteins, such as amphiphysin and endophilin 15, 16 . These interactions between endocytic accessory proteins have a pivotal role in clathrin-mediated endocytosis 17, 18 . Because EphB2-dependent phosphorylation occurs in the proline-rich domain, we examined how phosphorylation affects Anti-Myc C o n t r o l F c E p h r in B 2 − F c
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these interactions. In control 293T cells that had not been transfected with EphB2, endophilin was efficiently co-immunoprecipitated with synaptojanin 1 (lane 4 in Fig. 2a) . Cotransfection with EphB2, however, greatly reduced co-immunoprecipitation of endophilin (lane 5 in Fig. 2a,  c) . In contrast, co-immunoprecipitation of amphiphysin with synaptojanin 1 was not affected by phosphorylation (lanes 2 and 3 in Fig. 2a,  c) . The selective effect of phosphorylation on the interaction between synaptojanin 1 and endophilin, but not amphiphysin, was confirmed in an in vitro binding assay (Fig. 2b, d ) as well as in hippocampal neurons treated with ephrinB2, in which the components of the pathway are endogenously expressed (Fig. 2e, f) . The differential effect of EphB2-mediated synaptojanin 1 phosphorylation may be due to the fact that amphiphysin and endophilin bind to different sites in the proline-rich domain of synaptojanin 1 (ref. 19) . Consistent with this notion, binding of the Y1059F and Y1172F mutants to endophilin was much less sensitive to phosphorylation than binding of the Y1018F mutant (Fig. 2g, h) , 
whereas the mutations did not affect the interaction of synaptojanin with endophilin in the absence of EphB2 (data not shown). These observations suggest that Tyr 1059 and Tyr
1172
, but not Tyr
1018
, are the sites that are critical for the inhibition of the synaptojanin-endophilin interaction by phosphorylation. Taken together, these results indicate that EphB2-dependent phosphorylation at Tyr 1059 and Tyr 1172 differentially regulates the interactions of synaptojanin 1 with its binding partners.
The 5´-phosphatase domain of synaptojanin 1 catalyses the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) to phosphatidylinositol 4-monophosphate (PtdIns(4)P) (ref.
2). Interaction with endophilin has a role in the activation of the phosphatidylinositol 5´-phosphatase activity of synaptojanin 1 (ref. 20) . Hence, we examined whether EphB2-dependent tyrosine phosphorylation of synaptojanin 1 has an effect on 5´-phosphatase activity. In both B35-EphB2 cells stimulated with ephrinB2-Fc, and 293T cells transfected with EphB2, immunoprecipitated synaptojanin 1 showed a significantly lower 5´-phosphatase activity compared with synaptojanin 1 from control cells (Fig. 3a, b) . No such effects on the 5´-phosphatase activity were observed in 293T cells transfected with a kinase-inactive EphB2 (Fig. 3b) . We further examined which tyrosine residues are involved in phosphorylation-mediated inhibition of the 5´-phosphatase activity. Whereas the 5´-phosphatase activity of Y1018F was inhibited by transfection of EphB2 (Fig. 3c) , as was that of wild-type synaptojanin 1, the activity of the Tyr 1059 and/or Tyr 1172 mutants (Y1059F, Y1172F and Y1018F/Y1059F/Y1172F) was not decreased (Fig. 3c) . Thus, Tyr 1059 and Tyr 1172 are important both for EphB2-dependent modulation of the 5´-phosphatase activity of synaptojanin 1 and for the synaptojanin-endophilin interaction (see Fig. 2g , h). These results suggest that EphB2 inhibits the 5´-phosphatase activity of synaptojanin 1 by inhibiting the interaction with endophilin through tyrosine phosphorylation. EphrinB-EphB signalling not only reduces synaptojanin 5´-phosphatase activity but also increases cellular PtdIns(4,5)P 2 levels. An enzyme-linked immunosorbent assay (ELISA) using an anti-PtdIns(4,5)P 2 antibody demonstrated that PtdIns(4,5)P 2 levels are significantly higher in ephrinB2-treated cells than in control cells (Fig. 3d) . Overall, these results suggest that tyrosine phosphorylation in the proline-rich domain has an important regulatory role on the function of synaptojanin 1.
To investigate the effect of ephrinB-EphB signalling on clathrinmediated endocytosis, we analysed uptake of transferrin -which is internalized through a clathrin-dependent pathway -in B35-EphB2 cells in an assay with biotinylated transferrin. Pretreatment of B35-EphB2 cells with ephrinB2 increased transferrin uptake by approximately twofold compared with control Fc-treated cells (Fig. 4a, b ). An increase in transferrin uptake following ephrinB2 treatment was 
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also observed in an assay using transferrin that was conjugated with the fluorescent dye, Alexa-488 (Fig. 4c, e) . This effect was neutralized by expression of a dominant-negative mutant of EphB2 (the kinaseinactive form) ( Fig. 4c, e ; lower panels), indicating that the increase in transferrin uptake by ephrinB2 is dependent on the tyrosine kinase activity of EphB2. The kinase-inactive EphB2 mutant did not affect transferrin uptake in control Fc-treated cells ( Fig. 4c, e ; upper panels).
Furthermore, transfection with a synaptojanin mutant (Y1059F/ Y1172F), in which the two functionally important tyrosine residues (Tyr 1059 and Tyr 1172 ) were mutated, inhibited the ephrinB2-mediated increase in transferrin uptake ( Fig. 4d, e ; lower panel), whereas wildtype synaptojanin 1 did not affect it ( Fig. 4d, e; upper panel) . Taken together, these results confirm that ephrinB-EphB signalling stimulates internalization through a clathrin-dependent pathway. 

Because EphB-dependent phosphorylation of synaptojanin 1 affects its interaction with endophilin ( Fig. 2) , EphB receptor activation can also have some effects on the fate of internalized clathrin vesicles. In control Fc-treated cells, incorporated transferrin showed a good colocalization with EEA1, an endosomal marker ( Fig. 4f, g ; upper panel). In contrast, incorporated transferrin did not colocalize with EEA1 in ephrinB2-treated cells (Fig. 4f, g; lower panel) , suggesting that transferrin is not transported to endosomes. Furthermore, clathrin-positive vesicles, visualized by immunocytochemistry with an anti-clathrin antibody, accumulated along the plasma membrane in ephrinB2-treated cells, whereas they were widely distributed in control cells (Fig. 4h) . Quantitatively, ephrinB2 treatment increases the total number of clathrin vesicles by approximately 1.5-fold compared with control (Fig. 4i) , and the number of clathrin vesicles in the vicinity of the plasma membrane by 2.2-fold (Fig. 4j) . These results suggest that EphB activation inhibits the late phases of endocytosis. This notion is consistent with the results that EphB-mediated phosphorylation inhibits the association of synaptojanin 1 with endophilin, which is thought to be important for clathrin uncoating 17, 18 . Thus, EphB activation seems to exert distinct effects in different phases of clathrin-mediated endocytosis: a promoting effect on the early phase and an inhibitory effect on the late phase.
Finally, we examined the effect of EphB-mediated tyrosine phosphorylation of synaptojanin 1 in a more physiological context. It has been demonstrated that EphB receptors are expressed in the postsynaptic sites in the adult brain and are involved in synaptic plasticity [21] [22] [23] . Endocytosis of AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)-type glutamate receptors has a critical role in synaptic long-term depression (LTD), and depends on clathrin-mediated mechanisms 24 . To investigate the role of EphB-synaptojanin 1 signalling in AMPA receptor endocytosis, we transfected cDNAs that encode kinaseinactive EphB2 and the Y1059F/Y1172F synaptojanin 1 mutant into primary hippocampal neurons. Because inhibition of EphB receptor signalling blocks dendritic spine formation in neurons cultured for less than 10 days 14 , these experiments were performed using more mature cultures, which had already developed spines. In control cultures, stimulation with AMPA ligands promoted internalization of GluR1, a subunit of AMPA receptors, as previously reported 25 ( Fig. 5a, d ; second column). In contrast, transfection with kinase-inactive EphB2, which interferes with B-class Eph receptors in a dominant-negative manner, inhibited GluR1 endocytosis in both cell body and dendrites (Fig. 5a,  d, column 3) . Kinase-inactive EphB2 did not affect surface expression levels (see Supplementary Information, Fig. S1a , c) nor total levels ( Fig. 5a ; bottom panel) of GluR1 in neurons. The Y1058F/Y1172F synaptojanin 1 mutant, but not wild-type synaptojanin 1, also prevented AMPA ligand-dependent GluR1 endocytosis ( Fig. 5a, d ; columns 4 and 5) without altering total and surface GluR1 levels (see Supplementary  Information, Fig. S1a, c) . Activation of NMDA (N-methyl-d-aspartate)-type glutamate receptors also induces GluR1 endocytosis, predominantly in dendrites 25 . In untransfected neurons, GluR1 was indeed internalized in dendrites in response to NMDA treatment ( Fig. 5b ; open arrowheads). Transfection with kinase-inactive EphB2 ( Fig. 5b ; left column) or Y1058F/Y1172F synaptojanin 1 mutant ( Fig. 5b ; right column), but not wild-type synaptojanin 1 ( Fig. 5b; middle column) , significantly attenuated the NMDA-dependent GluR1 endocytosis ( Fig. 5b, e; closed arrowheads) . Neurons transfected with short interfering RNA (siRNA) to inhibit expression of synaptojanin 1 ( Fig. 5c, arrowheads; Supplementary Information, Fig. S2 ), exhibited reduced ligand-induced GluR1 endocytosis following AMPA treatment (Fig. 5c, f) . Overall, these findings suggest that tyrosine phosphorylation of synaptojanin 1 by EphB receptors controls synaptic activity through the regulation of clathrin-mediated endocytosis in the postsynaptic sites. It has been previously reported that EphB receptors regulate synaptic plasticity through extracellular interaction with NMDA receptors 21, 22 . Our data show that EphB receptors also have a role in AMPA receptor endocytosis.
In this study, we identify a novel ephrinB-EphB signalling pathway, in which EphB-dependent phosphorylation of synaptojanin 1 modulates the interaction of endocytic proteins and phosphoinositide metabolism. Most of the recent studies concerning downstream signalling of Eph receptors have demonstrated that reorganization of the actin cytoskeleton is a major consequence of ephrin-Eph signalling 1 . However, a direct regulation of endocytic proteins by ephrin-Eph signalling was not entirely unexpected. For instance, ephrin-mediated growth cone collapse involves not only reorganization of the cytoskeleton but also membrane endocytosis 26 . In addition, we previously reported that EphB receptor activation regulates dendritic spine formation through intersectin 8 , a multidomain adaptor protein that also has a role in clathrin endocytosis 27, 28 . Ephrins and Eph receptors themselves undergo bidirectional endocytosis upon activation 29, 30 . This process does not appear to involve clathrin-mediated mechanisms, suggesting that Eph signalling may regulate both clathrindependent and -independent endocytosis.
Many aspects of the regulation of synaptojanin 1 by phosphorylation remain to be characterized. Cdk5-mediated serine phosphorylation (Ser 1142 ) in the proline-rich domain of synaptojanin 1 also negatively regulates the synaptojanin-endophilin interaction 20 . It is currently unclear whether there is a functional relationship between this serine phosphorylation and EphB-mediated tyrosine phosphorylation of synaptojanin 1. However, there are differences between serine and tyrosine phosphorylation of synaptojanin 1. For instance, Cdk5 phosphorylates not only synaptojanin 1 but also other endocytic proteins such as amphiphysin 31 . In contrast, EphB2 does not phosphorylate amphiphysin in 293T cells, and tyrosine phosphorylation of amphiphysin was not detected in the synaptosome fraction (see Supplementary Information, Fig. S3 ). These observations suggest that serine phosphorylation may influence additional steps of the clathrinmediated endocytic process.
One of the critical issues remaining to be addressed is how dephosphorylation of synaptojanin 1 is regulated. Whereas EphB receptor activation increases cellular levels of PtdIns(4,5)P 2 and stimulates clathrin-mediated endocytosis, clathrin vesicles accumulate near the plasma membrane. This is presumably due to the phosphorylationdependent inhibition of the 5´-phosphatase activity and interaction of synaptojanin 1 with endophilin, which are necessary for clathrin uncoating 3, 17, 18 . It is thus likely that the function of synaptojanin 1 is also regulated by a protein tyrosine phosphatase. A similar mechanism has been demonstrated for serine/threonine phosphorylation of endocytic proteins, in which calcineurin has a critical role 32 . The interplay between EphB tyrosine kinases and a protein tyrosine phosphatase may have a critical role in regulating the endocytic activity of cells that respond to external ephrin stimulation.
METHODS
Mammalian expression vectors. Synaptojanin 1 cDNA (U45479) was amplified by RT-PCR from rat brain total RNA and fused with the c-Myc epitope sequence (EQKLISEEDL) at its amino terminus (designated as Myc-Synj1). Myc-Synj1-∆Sac1 and Myc-Synj1-∆5´P were generated by deleting amino-acid residues 4-500 and 500-885, respectively, from the full-length cDNA. Myc-Synj1-∆PR was generated by mutating Glu 1012 into a stop codon. Single-, double-and triplepoint mutants of tyrosine residues were generated by mutating Tyr 1018 , Tyr 1059 and Tyr
1172
, individually or in combination, to phenylalanine. Flag-tagged EphB2 and its kinase-inactive form (EphB2 K662R ) have been previously described 14 . Wildtype EphA4 and its kinase-inactive form (EphA4 K653R ) were tagged with the Flag epitope sequence (DYKDDDDK) at the N terminus of the mature EphA4 protein.
Human amphiphysin 1 (U07616) and mouse endophilin 1 (U58886) were amplified by PCR from human and mouse brain cDNAs, respectively, and fused with the haemagglutinin (HA) epitope (YPYDVPDYA) at their N terminus. All cDNA inserts were sequenced and ligated to pcDNA3 (Invitrogen, Carlsbad, CA).
Cell culture and transfection. A stable EphB2-expressing cell line, EphB2-B35, was established by transfecting rat B35 neuroblastoma cells with chicken EphB2 cDNA. 293T cells were transfected by Lipofectamine 2000 (Invitrogen). Rat hippocampal neurons were cultured in Neurobasal medium containing B27 supplement under 5% CO 2 and 10% O 2 as described previously 14 . Transfection of hippocampal neurons was performed at 14 days in vitro (14 DIV) for endocytosis assay by the calcium phosphate precipitation method 14 .
Preparation of recombinant proteins. cDNA of synaptojanin 1 prolinerich domain (Synj1-PRD; amino-acid residues 1016-1292) was prepared by PCR from Myc-Synj1-pcDNA3 and was ligated to pCAL-n (Stratagene, La Jolla, CA), which is a plasmid for the production of calmodulin-binding peptide (CBP)-tagged protein. Recombinant CBP-Synj1-PRD was produced in Escherichia coli (BL21) and was purified by calmodulin resin (Stratagene) according to the manufacturer's protocol. cDNAs of SH3 domains of amphiphysin 1 (622-695) and endophilin 1 (290-352) were generated by PCR and ligated to pMAL-c2X (New England BioLabs, Beverly, MA). Recombinant maltose-binding protein (MBP)-SH3 domains were isolated from extract of E. coli by amylose resins (Novagen, Madison, WI). Tyrosine kinase domains (TKD; 624-889) of EphB2 were fused with glutathione S-transferase (GST) by ligation to pGEX4T-1 (Amersham, Piscataway, NJ) and were prepared by glutathione-Sepharose (Amersham).
Phosphorylation analyses.
For the mass spectrometric analysis, EphB2-B35 cells in five 10-cm dishes were incubated for 15 min in a CO 2 incubator with 20 µg per dish of ephrinB2-Fc (R&D Systems, Minneapolis, MN) or control Fc protein (Chemicon, Pittsburgh, PA), which had been multimerized with antihuman Fc antibody (Sigma, St Louis, MO). Cells were then lysed in PBS containing 1% Triton X-100, 1 µM Na 3 VO 4 , and protease inhibitor cocktail (Sigma), and immunoprecipitated with anti-phosphotyrosine antibody (PY-20)-conjugated agarose (Sigma). Precipitated materials were separated by SDS-PAGE and silver stained. Bands that were present specifically in ephrinB2-treated cells were excised, trypsinized, and subjected to MALDI-TOF analysis as described previously 14 . For the in vitro phosphorylation assay, CBP-Synj1-PRD (0.2 µg) was incubated with wild-type or kinase-inactive GST-EphB2-TKD, which had been coupled to glutathione-Sepharose, for 1 h at 37 °C in 25 mM HEPES (pH 7.4) containing 0.3 mM MnCl 2 , 0.2 mM Na 3 VO 4 , and 0.2 mM ATP. After reaction, the supernatant was subjected to immunoblotting with monoclonal anti-phosphotyrosine antibody (PY-20; BD Transduction Laboratories, San Diego, CA). CBP and linker in the Synj1-PRD contain no tyrosine residue. CBP-tagged protein was detected by blotting with biotinylated calmodulin (Calbiochem, San Diego, CA), followed by HRP-conjugated avidin (Sigma). For the analysis of endogenous synaptojanin 1 phosphorylation, hippocampal neurons at 17 DIV were treated with ephrinB2-Fc and lysed as described above. Cell lysates were immunoprecipitated with monoclonal anti-synaptojanin 1 (gift from P. De Camilli, Yale University) or polyclonal anti-EphB2 (ref. Protein-protein interaction. For the in vitro binding assay, tyrosine-phosphorylated (by GST-EphB2-TKD) or unphosphorylated CBP-Synj1-PRD (2 µg) was incubated with MBP-amphiphysin 1 or endophilin 1-SH3 domain coupled to amylose resins for 3 h at room temperature in TBS containing 0.1% Triton X-100 and 1 mM Na 3 VO 4 . After washing in 0.05% Triton X-100-TBS, precipitated materials were subjected to blotting with biotinylated calmodulin and HRP-conjugated avidin to detect CBP-Synj1-PRD bound to SH3 proteins. For the analysis of endogenous protein interaction, primary rat hippocampal neurons (10 DIV) were treated with ephrinB2-Fc for 20 min, as described above, and synaptojanin 1 was immunoprecipitated with monoclonal anti-synaptojanin 1 antibody. Bound amphiphysin and endophilin were detected by immunoblotting with monoclonal anti-amphiphysin (Stressgen, San Diego, CA) and polyclonal anti-endophilin (Zymed) antibodies, respectively. For the analysis of protein interaction in 293T cells, Myc-Synj1 was cotransfected with various combinations of constructs including HA-amphiphysin 1, HA-endophilin 1 and Flag-EphB2, and was immunoprecipitated with 9E10 agarose. The bound HA-tagged proteins were evaluated by immunoblotting with anti-HA antibody (3F10; Roche. Indianapolis, IN). The lower phase, which contains PtdIns(4,5)P 2 , was subjected to ELISA assays using monoclonal anti-PtdIns(4,5)P 2 antibody (KT10; Assay Designs, Ann Arbor, MI), biotinylated anti-mouse IgG antibody, and horseradish peroxidase-conjugated streptavidin-biotin complex (Vector, Burlingame, NH). The immunoreactivity was visualized by 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (Sigma) and the absorbance was measured at 405 nm.
Measurement of clathrin-coated vesicles. B35-EphB2 cells were fixed in methanol for 5 min at -20 °C after treatment with ephrinB2-Fc, and were permeabilized by 0.2% Triton X-100 in PBS for 10 min at 4 °C. Clathrin-coated vesicles were visualized with monoclonal anti-clathrin heavy-chain antibody (X22; Sigma) and Cy2 anti-mouse IgG antibody (Jackson ImmunoResearch, West Grove, PA). The fluorescence images near the bottom of cells were acquired by a Bio-Rad (Hercules, CA) MRC-1024 confocal microscope. Number of total and membraneassociated clathrin vesicles, which are localized along the plasma membrane, were counted by NIH Image. Statistical significance was evaluated by Student's t-test.
Transferrin receptor endocytosis. For the biotinylated transferrin uptake experiment, B35-EphB2 cells were plated into a 24-well plate. Cells were pretreated with ephrinB2-Fc as described above, and incubated with 50 µg ml −1 of biotinylated transferrin (Molecular Probes) in Opti-MEM for 15 min at 4 °C. After incubation, cells were briefly washed in Opti-MEM and then further incubated without transferrin for 0, 2 and 5 min in a CO 2 incubator. To strip unincorporated transferrin L E T T E R S from the cell surface, cells were treated with ice-cold acid solution (0.2 M acetic acid, 0.5 M NaCl) for 10 min on ice. Immediately after this treatment, cells were washed with PBS and lysed in SDS-sample buffer. Incorporated transferrin was detected by blotting with HRP-conjugated avidin (Sigma) and subjected to densitometric quantification. The level of incorporated transferrin was divided by that of total transferrin bound on the cell surface, which was measured in cells without acid stripping. The y-axis units in the bar graphs were obtained by normalization to control cells (control Fc-treated, 0 min). For fluorescent transferrin uptake experiments, cells were cultured on coverslips and incubated with Alexa-488-conjugated transferrin (50 µg ml −1 ; Molecular Probes) for 3 min after pretreatment with ephrinB2-Fc for 15 min. After acid stripping, cells were fixed and stained with M2 and 9E10 antibodies to identify transfected cells with Flag-tagged kinase-inactive EphB2 and Myc-tagged synaptojanin 1 constructs, respectively. Incorporation of transferrin was examined by a Bio-Rad MRC-1024 confocal microscope and was quantified by fluorescent intensities of transferrin using NIH Image. Statistical significance was evaluated by analysis of variance (ANOVA).
AMPA receptor endocytosis. Hippocampal neurons that had been transfected with expression plasmids at 14 DIV were incubated with a rabbit polyclonal antibody against the N-terminal portion of GluR1 (1:20; Oncogene, Cambridge, MA) in conditioned medium containing 2 µM tetrodotoxin (TTX) for 15 min in a CO 2 incubator at 16-18 DIV. After a brief washing with Neurobasal medium, neurons were stimulated with 100 µM AMPA or 50 µM NMDA + 50 µM CNQX for 1 min and incubated for 10 min without ligands. After fixation with 4% paraformaldehyde/4% sucrose in PBS for 10 min at room temperature, labelled surface GluR1 was blocked for 30 min at room temperature by excess non-labelled anti-rabbit antibody Fab fragment (Jackson ImmunoResearch) diluted in 3% normal goat serum in PBS (NGS-PBS). Cells were then permeabilized in 0.2% Triton X-100 in PBS, and internalized GluR1 was detected with Cy2-conjugated anti-rabbit IgG antibody Fab fragment. Expression of dominant-negative EphB2 and synaptojanin 1 constructs were verified by labelling with M2 and 9E10 antibodies and rhodamine Red-Xconjugated anti-mouse IgG antibody (Jackson ImmunoResearch). For detection of total GluR1, cells were incubated with rabbit polyclonal anti-GluR1 antibody against the C-terminal portion (Upstate), followed by Cy5-conjugated anti-rabbit IgG antibody (Jackson ImmunoResearch). Fluorescent images were acquired using a Bio-Rad MRC-1024 confocal microscope. Intensities of immunoreactive puncta of internalized GluR1 in 20-25 dendrites were analysed using NIH Image software in a blinded manner. The y-axis units in the bar graphs were obtained by normalization to untreated control cells. Statistical significance was evaluated by ANOVA. siRNA transfection. siRNAs for synaptojanin 1 (siRNA#7: AAUGUCUCAUGUUCGAGUCUG, 227-248 base pairs (bp); siRNA#9: AAGGAGGCCAUUAAAGGCACA, 277-298 bp) were designed according to the rat sequence (U45479) and produced by Dharmacon (Lafayette, CO). Scramble siRNA (Scramble I duplex; Dharmacon) was used as a control. Hippocampal neurons were transfected with Synj1 siRNAs at 16 DIV. Two microlitres of 20 µM siRNA were mixed with 1 µl of Enhancer R and 2 µl of TransMessenger reagent (Qiagen, Valencia, CA) as described in the manufacturer's instructions, and diluted in 300 µl of Neurobasal-B27 medium without antibiotics. At 2.5 h after transfection, transfection medium was replaced with the original conditioned medium.
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